C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/44 (2006.01) A61K 39/395 (2006.01) A61P 3/00 (2006.01) A61P 9/12 (2006.01) C12N 5/20 (2006.01) G01N 33/53 (2006.01)
Patent
CA 2386519
The invention relates to a monoclonal antibody or antigen binding fragment thereof having binding specificity for ouabain, wherein the antibody or antigen binding fragment does not crossreact with digoxin. Preferably the anti- ouabain monoclonal antibody can bind ouabain with an affinity of at least about 10-7M, preferably 10-8M, and more preferably 10-9M. The invention also relates to diagnostic and therapeutic uses of the monoclonal antibodies described herein.
L'invention concerne un anticorps monoclonal ou un fragment de celui-ci liant l'antigène, possédant une spécificité de liaison à la ouabaïne. Cet anticorps ou fragment liant l'antigène ne produit pas de réaction croisée avec la digoxine. L'affinité de liaison de cet anticorps monoclonal anti-ouabaïne avec la ouabaïne atteint de préférence au moins 10?-7¿M environ, voire 10?-8¿M, ou mieux encore 10?-9¿M. L'invention concerne également des utilisations diagnostiques et thérapeutiques de ces anticorps monoclonaux.
Haupert Garner T. Jr.
Margolies Michael N.
Parhami-Seren Behnaz
Gowling Lafleur Henderson Llp
The General Hospital Corporation
LandOfFree
Ouabain-specific monoclonal antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ouabain-specific monoclonal antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ouabain-specific monoclonal antibodies will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1359438